Cresco Labs Inc. (CRLBF)
OTCMKTS · Delayed Price · Currency is USD
1.090
+0.107 (10.93%)
Aug 18, 2025, 2:45 PM EDT
Cresco Labs Market Cap
Cresco Labs has a market cap or net worth of $340.58 million as of August 18, 2025. Its market cap has decreased by -39.21% in one year.
Market Cap
340.58M
Enterprise Value
736.51M
Revenue
677.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.09
Market Cap Chart
Since December 3, 2018, Cresco Labs's market cap has decreased from 627.84M to 340.58M, a decrease of -45.75%. That is a compound annual growth rate of -8.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 340.58M | 6.43% |
| Dec 31, 2024 | 320.01M | -30.65% |
| Dec 29, 2023 | 461.48M | -15.53% |
| Dec 30, 2022 | 546.30M | -71.66% |
| Dec 31, 2021 | 1.93B | -17.69% |
| Dec 31, 2020 | 2.34B | 148.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.94M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |